Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
N-Power Medicine is a biotechnology company that incorporates AI to offer clinical research and drug development services.
CND Life Sciences is a medical technology company that develops evidence-based tool to assist physicians in diagnosing synucleinopathy.
Teal Health is a health tech company that develops cervical cancer screening and communication platforms.
Biospectal mission to reinvent medical sensing and monitoring through ubiquitous connected devices, IoT, and edge computing technologies.
PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.
Circuit Clinical is an integrated research organization providing turnkey end-to-end solutions for clinical trials.
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.
GeneCentric Therapeutics develops and commercializes molecular diagnostic tests for oncologists and patients.
Outcomes4Me develops direct-to-patient AI-driven platform designed to assist cancer patients in managing their care.
Percipio Health uses AI based insights to help clinicians and caregivers maintain holistic view of a patient's health.
Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.
NOWDiagnostics develops and manufactures diagnostic tests that utilize a single drop of blood and deliver results within minutes.
Acclinate leverages sustained engagement and AI-driven insights to empower communities to take actions for better health.
Vital Bio is designing a new generation of tools to empower patients in monitoring health and managing the disease.
KIYATEC utilizes the patient's own living tumor cells to create functional 3D models to test a battery of cancer therapies.
Prognos Health creates a healthcare analytics platform that uses patient-level data to generate clinical insights.
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
Prenosis develops data-driven diagnostic tools and precision medicine solutions for acute care conditions.
PetDx is a molecular diagnostics company dedicated to the detection and treatment of cancer in pets.
Phenomix Sciences is a biotechnology company that specializes in biotech, life science, metabolomics, and genomics.
Cellens is a medical device company that provides clarity and focus on cancer detection.
Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.
SiteLabs engages in testing platform option that will streamline and automate your testing process workflow.
LabCorp has invested in 43 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
LabCorp's top investment sectors include Health Care, Health Diagnostics, Biotechnology, Medical, Life Science. The firm invests across 26 different industry categories.
Among tracked funding rounds, Geneoscopy received $105.0M in a Series C round. LabCorp's total known invested capital is $693.8M.
LabCorp's average investment size is $18.8M across its portfolio of 43 companies.
Recent LabCorp portfolio additions include N-Power Medicine, CND Life Sciences, Teal Health, Biospectal, PreciseDx. These companies were founded in 2020 or later.